Skip to main content
GoodMoatv1.3
Sign in
TAK logo

TAK

CompareEarnings: Aug 31, 2026

Takeda Pharmaceutical Company

Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Values in USD · ADR · Reports in JPY

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

Current Price

$16.68

+0.60%

GoodMoat Value

$44.87

169.0% undervalued
Profile
Valuation (TTM)
Market Cap$52.11B
P/E73.27
EV—
P/B1.12
Shares Out3.12B
P/Sales1.75
Revenue$29.80B
EV/EBITDA9.47

Takeda Pharmaceutical Company (TAK) Company Profile

TAK Company Information

Takeda is focused on creating better health for people and a brighter future for the world.

We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.

Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline.

As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet.

Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSE

Country

Japan

TAK Key Officers

Key officers data coming soon

TAK Company Profile

Takeda Pharmaceutical Company (TAK) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. It trades on NYSE. The company is based in Japan.

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

Market cap is $52.11B. There are 3124.0M shares outstanding. Dividend yield is 3.89%.

See the full Takeda Pharmaceutical Company profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if TAK is a good investment.